Stephen E. Kimmel

faculty photo
Professor of Medicine
Attending, Veterans Affairs Medical Center
Director, Cardiovascular Epidemiology, Cardiovascular Division, Department of Medicine, Perelman School of Medicine University of Pennsylvania
Senior Scholar, Perelman School of Medicine University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics (CCEB)
Senior Fellow, Leonard Davis Institute
Director, Center for Therapeutic Effectiveness Research, Perelman School of Medicine University of Pennsylvania
Senior Fellow, Center for Behavioral Health Research, University of Pennsylvania
Director of the Division of Clinical Epidemiology and the Clinical Epidemiology Unit , Perelman School of Medicine University of Pennsylvania
Member, American Epidemiological Society
Department: Medicine

Contact information
University of Pennsylvania School of Medicine
Center for Clinical Epidemiology and Biostatistics
Room 923, Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-898-1740
Fax: 215-573-3106
Graduate Group Affiliations
A.B. (Chemistry)
Princeton University, Princeton, NJ , 1984.
M.D. (Medicine)
New York University School of Medicine, New York, NY, 1988.
M.S.C.E. (Clinical Epidemiology)
Perelman School of Medicine University of Pennsylvania, 1995.
Permanent link

Description of Research Expertise

Epidemiology, pharmacoepidemiology, cardiology

Description of Itmat Expertise

Dr. Kimmel performs clinical studies of medications and randomized trials of interventions to improve medical treatments. His work includes large-scale population studies, multicenter clinical trials, and patient-centered outcome reaserch.

Selected Publications

Schelleman H, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD, Kimmel SE : The Effect of Selective Serotonin Reuptake Inhibitors on The Risk of Myocardial Infarction in a Cohort of Patients With Depression. British Journal of Clinical Pharmacology 72: 514-517, 2011.

Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S: Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127(6): 1102-1110, 2011.

Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MTM, Pirmohamed M, Wadelius M, Klein TE, Altman RB: Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clinical Pharmacology and Therapeutics 90(4): 625-629, 2011.

Leonard CE, Bilker WB, Newcomb C, Kimmel SE, Hennessy S: Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiology and Drug Safety 20: 903-13, 2011.

Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79: 250-257, 2011.

Finkelman BS, Gage BF, Johnson JA, Brensinger CM, Kimmel SE: Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol 57: 612-618, 2011.

Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM: Validity of The Health Improvement Network (THIN) for the study of psoriasis. British Journal of Dermatology 164(3): 602-609, 2011.

Wade KC, Ellenberg JH, Grosser T, Brensinger CM, Kimmel SE, Hennessy S: Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women. Journal of Cardiovascular Pharmacology 57(2): 194-200, 2011.

Joo J, Geller N, French B, Kimmel S, Rosenberg Y, Ellenberg J: Prospectve Alpha Allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) Trial. Clin Trials 7: 597-604, 2010.

Schelleman H, Brensinger CM, Chen J, Finkelman BS, Rieder MJ, Kimmel SE: New genetic variant that might improve warfarin dose prediction in African Americans. Br J Clin Pharmacol 70: 393-399, 2010

back to top
Last updated: 09/26/2018
The Trustees of the University of Pennsylvania